DBV Technologies SA (DBVT)
18.54
+0.38
(+2.06%)
USD |
NASDAQ |
May 27, 16:00
18.54
0.00 (0.00%)
After-Hours: 16:45
DBV Technologies Cash from Investing (Quarterly) : -0.3011M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cellectis SA | -6.187M |
| Akari Therapeutics Plc | 0.00 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1037M |
| Autolus Therapeutics Plc | 95.99M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -49.28M |
| Cash from Financing (Quarterly) | 89.22M |
| Free Cash Flow | -152.10M |
| Free Cash Flow Per Share (Quarterly) | -0.58 |
| Free Cash Flow to Equity (Quarterly) | -44.30M |
| Free Cash Flow to Firm (Quarterly) | -49.68M |
| Free Cash Flow Yield | -18.42% |